CUSIP: 36118A100
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,647,999
-
Share change
-
-2,525,366
-
Total reported value
-
$306,186,361
-
Price per share
-
$12.02
-
Number of holders
-
29
-
Value change
-
-$39,971,461
-
Number of buys
-
10
-
Number of sells
-
35
Quarterly Holders Quick Answers
What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 36118A100:
Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q3 2020
As of 30 Sep 2020,
FUSION PHARMACEUTICALS INC - COM (FUSN) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,647,999 shares.
The largest 10 holders included
Johnson & Johnson Innovation - JJDC, Inc., ADAMS STREET PARTNERS LLC, ORBIMED ADVISORS LLC, FMR LLC, CANADA PENSION PLAN INVESTMENT BOARD, TPG Group Holdings (SBS) Advisors, Inc., PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Rock Springs Capital Management LP, and FEDERATED HERMES, INC..
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.